US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Ligand Pharmaceuticals Incorporated - Common Stock (NQ:LGND)

302.96 +0.22 (+0.07%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ligand Pharmaceuticals Incorporated - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Ligand Pharmaceuticals Inc (LGND) Q1 2021 Earnings Call Transcript ↗
LGND earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Gainers Precipio (NASDAQ: 
Via Benzinga
News headline image
Recap: Ligand Pharmaceuticals Q1 Earnings ↗
Shares of Ligand Pharmaceuticals (NASDAQ:LGND) fell 7% in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 58.43% over the... 
Via Benzinga
News headline image
Ligand Reports First Quarter 2021 Financial Results
From Ligand Pharmaceuticals Incorporated
Via Business Wire
News headline image
Short Interest Report: B&G Foods Short Position At Three-Month Highs ↗
Estimated short interest in B&G Foods has accelerated its gains, spiking on Monday and also rising for four out of five trading sessions. For the week, B&G Foods short interest was up 22% at 28.94% of... 
Via Talk Markets
News headline image
Earnings Scheduled For May 3, 2021 ↗
Companies Reporting Before The Bell • Scienjoy Holding (NASDAQ:SJ) is estimated to report quarterly earnings at $0.58 per share on revenue of $540.11 million. •... 
Via Benzinga
News headline image
Ligand to Report First Quarter Financial Results on May 3, 2021
From Ligand Pharmaceuticals Incorporated
Via Business Wire
News headline image
3 Signs the Ligand Short Squeeze Is Over ↗
The Reddit crowd wasn't the only reason short-sellers got burned betting against this pharmaceutical company. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9 Next >